The global hydroxychloroquine market is projected to grow from USD 4.21 billion in 2024 to USD 6.85 billion by 2034, registering a CAGR of 5% during the forecast period.
Hydroxychloroquine (HCQ) has long been recognized for its role in the treatment of malaria and autoimmune diseases like rheumatoid arthritis and lupus. This pharmaceutical compound gained...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek